Jesper Glückstad, Mark Villangca, Andrew Banas and Darwin Palima had
their postdeadline paper accepted at this year's EOS Topical Meetings in
Italy 12-14 September.
The paper demonstrates new techniques for exploration into how the brain works. The ultimate aim is the prevention of diseases such as Alzheimers and Parkinsons.
The postdeadline paper demonstrates the newest applications of the proprietary GPC and mGPC techniques for use in spatio-temporal light encoding with a plurality of uses in contemporary optics and photonics - especially for two-photon parallel light adressing in neuro-photonics and optogenetics which are strongly emerging fields internationally within biophotonics on the cellular level.
DTU Fotonik's patented GPC and mGPC is currently being explored by leading groups in the world among them Oxford Univ. and Paris Descartes Univ. for selectively adressing genetically modified - and light sensitive - living brain cells from mouse embryoes and fruit flies. Using two photon optogenetics, the aim is to come up with an understanding of how neural networks or brains work and to ultimately be able to prevent e.g. Alzheimers and Parkinsons diseases.